Skip to main content
Monday, November 16, 2026Nov 16

Sohn: Forget Trump’s COVID-19 talks, follow the money – if you can find it

Anna Moneymaker, The New York Times / President Donald Trump held up a test swab during a coronavirus briefing at the White House on April 19 as he talked about preparing to use the Defense Production Act to compel an unspecified U.S. facility to increase production of test swabs by over 20 million per month.
Anna Moneymaker, The New York Times / President Donald Trump held up a test swab during a coronavirus briefing at the White House on April 19 as he talked about preparing to use the Defense Production Act to compel an unspecified U.S. facility to increase production of test swabs by over 20 million per month.

We all breathed a sigh of relief when President Donald Trump and his administration finally said they would use the Defense Production Act to ramp up orders for tests and medical supplies in the fight against COVID-19.

But we forgot one important fact. We’re talking about the Trump administration.

And what little we already know about the president’s use of the Defense Production Act – a Truman-era law – is not encouraging, according to consumer watchdog and U.S. Rep. Katie Porter, D-California.

“Unlike most government contracts, DPA orders are not public documents, leaving Americans in the dark about one of the administration’s key tools in its COVID-19 response,” Porter wrote in a Tuesday opinion piece in The Washington Post. She ticked off a few examples:

* A $96 million no-bid contract for respirators that went to a company with no background in medical supplies. According to federal procurement documents, the contract was ordered by the White House. (More on this later.)